Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
Emin Gemcioğlu, Mehmet Davutoğlu, Ese Ece Ozdemir, Abdülsamet Erden
Topics & Concepts
MedicineMultiple sclerosisCoronavirus disease 2019 (COVID-19)PandemicCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineDiseaseInternal medicineImmunologyInfectious disease (medical specialty)Long-Term Effects of COVID-19Multiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 Research